Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-22T06:47:41.559Z Has data issue: false hasContentIssue false

Tratamiento antihormonal de pacientes parafílicos en clínicas psiquiátricas forenses alemanas

Published online by Cambridge University Press:  12 May 2020

J.P. Czerny
Affiliation:
Departamento de Sexología (Director: Prof. Dr. W. Berner), Clínica de Psiquiatría y Psicoterapia de la Universidad de Hamburgo, Martinistrasse 52, 20246Hamburgo, Alemania
P. Briken
Affiliation:
Departamento de Sexología (Director: Prof. Dr. W. Berner), Clínica de Psiquiatría y Psicoterapia de la Universidad de Hamburgo, Martinistrasse 52, 20246Hamburgo, Alemania
W. Berner
Affiliation:
Departamento de Sexología (Director: Prof. Dr. W. Berner), Clínica de Psiquiatría y Psicoterapia de la Universidad de Hamburgo, Martinistrasse 52, 20246Hamburgo, Alemania
Get access

Resumen

El propósito de este estudio era investigar qué estrategias de tratamiento antihormonal se utilizan en las instituciones psiquiátricas forenses alemanas. Se preguntó a las clínicas forenses por el número de pacientes tratados. Cuatrocientos setenta y cuatro pacientes estaban internados por delitos sexuales; el 12% recibía CPA (n = 29) o agonistas de la luliberina (n = 29). Las diferencias en eficacia eran pequeñas. Varios efectos secundarios confirman la importancia de un protocolo para minimizar las complicaciones médicas.

Type
Comunicación Breve
Copyright
Copyright © European Psychiatric Association 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Briken, PBerner, WNoldus, J.Nika, EMichl, U.Therapy of paraphilia with LHRH-agonists. WPA-Abseract, XI World Congress of Psychiatry. Curr Opin Psychiatry 1999;12(Suppl 1):150.Google Scholar
Briken, PBemer, WNoldus, JNika, EMichl, U.Therapie mit dem LHRH-Agonisten Leuprorelinacetat bei Paraphilien* und sexuelll aggressiven Impulshhandlungen. Nervenarzt 2000;71:380–5.CrossRefGoogle Scholar
Briken, PNika, EBerner, W.Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther 2001;27:4555.Google ScholarPubMed
Cooper, AJCernowsky, Z.Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study. Biol Psychiatry 1994;36:269–71.CrossRefGoogle Scholar
Dickey, R.The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 1992;37:567–9.CrossRefGoogle ScholarPubMed
Reilly, DRDeiva, NJHudson, RW.Protocols of the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Can J Psychiatry 2000;45:559–63.CrossRefGoogle ScholarPubMed
Rösler, AWitztum, E.Treatment of men with paraphilia with long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 1998;338:416–22.CrossRefGoogle ScholarPubMed
Rösler, AWitztum, E.Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law 2000;18:4356.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Rousseau, LCouture, MDupont, ALabrie, FCouture, N.Effect of combined androgen blockade with an LHRH agonist and flutamine in one severe case of male exhibitionism. Can J Psychiatry 1990;35:338–41.Google Scholar
Thibaut, FCordier, BKuhn, JM.Gonadotropin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment? Psychoneuroendocrinology 1996;21:411–9.CrossRefGoogle ScholarPubMed